#drug approval
2 stories
Life-extending breast cancer drug now on NHS
After price negotiations, thousands of women with advanced HER2-low breast cancer will access Enhertu on the NHS from Thursday.
the Guardian · 1m
A new SMA drug goes after the muscle itself
Isembyld is the first SMA therapy cleared to treat muscle loss directly, and it works on top of the drugs patients already take.
Dallas Express · 1m